Assessment of Pretreatment Diffusion Parameters in Low- and Intermediate-Risk Prostate Cancer Patients Treated with Stereotactic Ablative Radiotherapy

被引：0
|
作者：
Kedves, A. [1 ,2 ,3 ]
Kisivan, K. [1 ]
Glavak, C. [1 ]
Lorincz, A. [3 ,4 ]
Kovacs, A. [2 ,5 ,6 ]
Lakosi, F. [1 ,2 ,5 ]
机构：
[1] Moritz Kaposi Teaching Hosp, Dr Jozsef Baka Diagnost Radiat Oncol Res & Teachi, Kaposvar, Hungary
[2] Univ Pecs, Doctoral Sch Hlth Sci, Pecs, Hungary
[3] Univ Pecs, Inst Informat & Elect Technol, Fac Engn & Informat Technol, Pecs, Hungary
[4] Univ Pecs, Inst Translat Med, Med Sch, Pecs, Hungary
[5] Univ Pecs, Dept Med Imaging, Fac Hlth Sci, Pecs, Hungary
[6] Univ Debrecen, Dept Oncoradiol, Fac Med, Debrecen, Hungary
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-336
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
    Kishan, Amar U.
    King, Christopher R.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2017, 27 (03) : 268 - 278
  • [2] Stereotactic ablative radiotherapy for low to intermediate risk prostate cancer
    Sadozye, A.
    Dodds, D.
    MacLeod, N.
    Lamb, C.
    Smith, S.
    Foster, J.
    Devlin, L.
    Dufton, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S679 - S680
  • [3] Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
    Kim, Hun Jung
    Phak, Jeong Hoon
    Kim, Woo Chul
    [J]. RADIATION ONCOLOGY JOURNAL, 2016, 34 (04): : 260 - 264
  • [4] Predictive value of magnetic resonance imaging diffusion parameters using artificial intelligence in low-and intermediate-risk prostate cancer patients treated with stereotactic ablative radiotherapy: A pilot study
    Kedves, A.
    Akay, M.
    Akay, Y.
    Kisivan, K.
    Glavak, C.
    Miovecz, A.
    Schiffer, A.
    Kisander, Z.
    Lorincz, A.
    Szoke, A.
    Santa, B.
    Freihat, O.
    Sipos, D.
    Kovacs, A.
    Lakosi, F.
    [J]. RADIOGRAPHY, 2024, 30 (03) : 986 - 994
  • [5] Pure Hypofractionated Radiotherapy for the Treatment of Low- to Intermediate-Risk Prostate Cancer
    Stephens, R.
    Gopaul, D.
    Panjwani, D.
    Lock, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S732 - S732
  • [6] Management of low- and intermediate-risk prostate cancer
    Henk van der Poel
    Laurence Klotz
    Christian G. Stief
    [J]. World Journal of Urology, 2015, 33 : 905 - 906
  • [7] Management of low- and intermediate-risk prostate cancer
    van der Poel, Henk
    Klotz, Laurence
    Stief, Christian G.
    [J]. WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 905 - 906
  • [8] Radiotherapy in low and intermediate-risk prostate cancer
    Yalman, Deniz
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 86 - 91
  • [9] Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?
    Helou, Joelle
    D'Alimonte, Laura
    Quon, Harvey
    Deabreu, Andrea
    Commisso, Kristina
    Cheung, Patrick
    Chu, William
    Mamedov, Alexandre
    Davidson, Melanie
    Ravi, Ananth
    Loblaw, Andrew
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 (03) : 478 - 482
  • [10] Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy
    Cheung, R
    Tucker, SL
    Lee, AK
    De Crevoisier, R
    Dong, L
    Kamat, A
    Pisters, L
    Kuban, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 993 - 1002
12345